US 9585935
Intranasal oxytocin treatment to improve schizophrenia
granted A61KA61K38/095A61K9/0043
Quick answer
US patent 9585935 (Intranasal oxytocin treatment to improve schizophrenia) held by The Regents of the University of California expires Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Mar 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K38/095, A61K9/0043, A61P, A61P25/00